Skip to main content
. 2011 Apr;12(2):130–137. doi: 10.2174/138920211795564359

Fig. (2).

Fig. (2)

Schematic representation of alterations in p53/ARF and RB/INK4A pathways in HCC. Molecules with oncogenic function are shown in yellow and those with tumor suppressive function are shown in blue. Specific type of genetic and epigenetic alterations found in HCC are shown in red letter.